1. Home
  2. CRGO vs XBIT Comparison

CRGO vs XBIT Comparison

Compare CRGO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$0.80

Market Cap

66.7M

Sector

Finance

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

SELL

Current Price

$2.22

Market Cap

69.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRGO
XBIT
Founded
2012
2005
Country
Spain
United States
Employees
N/A
N/A
Industry
Blank Checks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.7M
69.8M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
CRGO
XBIT
Price
$0.80
$2.22
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $2.80
N/A
AVG Volume (30 Days)
★ 74.3K
32.2K
Earning Date
11-16-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.32
N/A
Revenue Next Year
$10.35
$30.47
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.79
$2.09
52 Week High
$4.24
$3.44

Technical Indicators

Market Signals
Indicator
CRGO
XBIT
Relative Strength Index (RSI) 29.59 51.97
Support Level N/A $2.15
Resistance Level $1.43 $2.46
Average True Range (ATR) 0.07 0.05
MACD -0.01 0.01
Stochastic Oscillator 2.76 45.00

Price Performance

Historical Comparison
CRGO
XBIT

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: